Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Prospective associations between plasma saturated, monounsaturated and polyunsaturated fatty acids and overall and breast cancer risk - modulation by antioxidants: a nested case-control study.

Pouchieu C, Chajès V, Laporte F, Kesse-Guyot E, Galan P, Hercberg S, Latino-Martel P, Touvier M.

PLoS One. 2014 Feb 27;9(2):e90442. doi: 10.1371/journal.pone.0090442.

2.

Prospective association between red and processed meat intakes and breast cancer risk: modulation by an antioxidant supplementation in the SU.VI.MAX randomized controlled trial.

Pouchieu C, Deschasaux M, Hercberg S, Druesne-Pecollo N, Latino-Martel P, Touvier M.

Int J Epidemiol. 2014 Oct;43(5):1583-92. doi: 10.1093/ije/dyu134.

3.

Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's Health Study.

Saadatian-Elahi M, Toniolo P, Ferrari P, Goudable J, Akhmedkhanov A, Zeleniuch-Jacquotte A, Riboli E.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1353-60.

4.

Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers.

Takata Y, King IB, Neuhouser ML, Schaffer S, Barnett M, Thornquist M, Peters U, Goodman GE.

Cancer Causes Control. 2009 May;20(4):497-504. doi: 10.1007/s10552-009-9314-2.

5.
6.

Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China.

Shannon J, King IB, Moshofsky R, Lampe JW, Gao DL, Ray RM, Thomas DB.

Am J Clin Nutr. 2007 Apr;85(4):1090-7.

7.

A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk.

Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1364-70.

8.

Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study.

Pouchieu C, Galan P, Ducros V, Latino-Martel P, Hercberg S, Touvier M.

Nutr Cancer. 2014;66(6):980-8. doi: 10.1080/01635581.2014.936952.

PMID:
25072980
9.

Serum fatty acids and breast cancer incidence.

Rissanen H, Knekt P, Järvinen R, Salminen I, Hakulinen T.

Nutr Cancer. 2003;45(2):168-75.

PMID:
12881010
10.

Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids.

Kuriki K, Wakai K, Hirose K, Matsuo K, Ito H, Suzuki T, Saito T, Kanemitsu Y, Hirai T, Kato T, Tatematsu M, Tajima K.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1791-8.

11.
12.

Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study.

Pala V, Krogh V, Muti P, Chajès V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F.

J Natl Cancer Inst. 2001 Jul 18;93(14):1088-95.

13.

Role of fatty acids in malignancy and visual impairment: epidemiological evidence and experimental studies.

Tsubura A, Yuri T, Yoshizawa K, Uehara N, Takada H.

Histol Histopathol. 2009 Feb;24(2):223-34. Review.

PMID:
19085838
14.

Prospective study of plasma fatty acids and risk of prostate cancer.

Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ.

J Natl Cancer Inst. 1994 Feb 16;86(4):281-6. Erratum in: J Natl Cancer Inst 1994 May 4;86(9):728.

PMID:
8158682
15.

Development of a food-exchange model to replace saturated fat with MUFAs and n-6 PUFAs in adults at moderate cardiovascular risk.

Weech M, Vafeiadou K, Hasaj M, Todd S, Yaqoob P, Jackson KG, Lovegrove JA.

J Nutr. 2014 Jun;144(6):846-55. doi: 10.3945/jn.114.190645.

16.

Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault MC, Engel P, Teucher B, Kaaks R, Floegel A, Boeing H, Trichopoulou A, Dilis V, Karapetyan T, Mattiello A, Tumino R, Grioni S, Palli D, Vineis P, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Lund E, Navarro C, Quirós JR, Sánchez-Cantalejo E, Gurrea AB, Dorronsoro M, Regnér S, Sonestedt E, Wirfält E, Khaw KT, Wareham N, Allen NE, Crowe FL, Rinaldi S, Slimani N, Carneiro F, Riboli E, González CA.

Am J Clin Nutr. 2011 Nov;94(5):1304-13. doi: 10.3945/ajcn.110.005892.

17.

Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.

Wu JH, Lemaitre RN, King IB, Song X, Psaty BM, Siscovick DS, Mozaffarian D.

Circulation. 2014 Oct 7;130(15):1245-53. doi: 10.1161/CIRCULATIONAHA.114.011590.

18.

Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer.

Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L.

Int J Cancer. 1997 May 16;71(4):545-51.

19.
20.

Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer.

London SJ, Sacks FM, Stampfer MJ, Henderson IC, Maclure M, Tomita A, Wood WC, Remine S, Robert NJ, Dmochowski JR, et al.

J Natl Cancer Inst. 1993 May 19;85(10):785-93.

PMID:
8487323
Items per page

Supplemental Content

Support Center